Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscular Atrophy, Spinal | 59 | 2024 | 258 | 15.910 |
Why?
|
Spinal Muscular Atrophies of Childhood | 54 | 2024 | 115 | 13.260 |
Why?
|
Muscular Dystrophy, Duchenne | 39 | 2024 | 267 | 5.820 |
Why?
|
Neuromuscular Diseases | 13 | 2024 | 258 | 2.740 |
Why?
|
Oligonucleotides | 13 | 2024 | 582 | 2.320 |
Why?
|
Muscle, Skeletal | 39 | 2023 | 4948 | 2.150 |
Why?
|
Muscular Dystrophies | 22 | 2023 | 390 | 2.030 |
Why?
|
Deglutition Disorders | 6 | 2023 | 625 | 1.820 |
Why?
|
Electromyography | 25 | 2019 | 1394 | 1.610 |
Why?
|
Survival of Motor Neuron 1 Protein | 9 | 2021 | 64 | 1.540 |
Why?
|
Myography | 8 | 2021 | 111 | 1.480 |
Why?
|
Electric Impedance | 11 | 2021 | 757 | 1.110 |
Why?
|
Myopathies, Structural, Congenital | 6 | 2023 | 103 | 1.100 |
Why?
|
Child | 142 | 2024 | 80156 | 0.990 |
Why?
|
Child, Preschool | 107 | 2024 | 42230 | 0.980 |
Why?
|
Azo Compounds | 3 | 2022 | 117 | 0.980 |
Why?
|
Infant | 79 | 2024 | 36192 | 0.940 |
Why?
|
Glycogen Storage Disease Type II | 3 | 2021 | 43 | 0.870 |
Why?
|
Neuromuscular Agents | 2 | 2021 | 147 | 0.830 |
Why?
|
Disease Progression | 30 | 2024 | 13510 | 0.770 |
Why?
|
Disability Evaluation | 11 | 2024 | 1836 | 0.770 |
Why?
|
Insurance | 1 | 2023 | 113 | 0.750 |
Why?
|
Muscular Diseases | 10 | 2018 | 553 | 0.720 |
Why?
|
Motor Neurons | 10 | 2023 | 870 | 0.700 |
Why?
|
Adrenal Cortex Hormones | 5 | 2020 | 1881 | 0.700 |
Why?
|
Neural Conduction | 14 | 2018 | 441 | 0.660 |
Why?
|
Adolescent | 101 | 2024 | 88324 | 0.650 |
Why?
|
Myopathies, Nemaline | 3 | 2014 | 73 | 0.640 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 4 | 2016 | 48 | 0.630 |
Why?
|
Muscle Proteins | 10 | 2014 | 1154 | 0.630 |
Why?
|
Intermediate Filaments | 1 | 2019 | 172 | 0.620 |
Why?
|
Humans | 261 | 2024 | 761572 | 0.600 |
Why?
|
Upper Extremity | 7 | 2024 | 658 | 0.600 |
Why?
|
Dystrophin | 13 | 2023 | 283 | 0.590 |
Why?
|
Pregnenediones | 5 | 2022 | 29 | 0.570 |
Why?
|
Arthrogryposis | 2 | 2010 | 68 | 0.550 |
Why?
|
Ethics, Medical | 1 | 2022 | 783 | 0.540 |
Why?
|
Mutation | 34 | 2023 | 30054 | 0.530 |
Why?
|
Prednisone | 6 | 2022 | 1563 | 0.520 |
Why?
|
Neurology | 3 | 2020 | 780 | 0.510 |
Why?
|
Pyrimidines | 4 | 2022 | 3028 | 0.500 |
Why?
|
Survival of Motor Neuron 2 Protein | 9 | 2024 | 49 | 0.500 |
Why?
|
Phenotype | 16 | 2022 | 16592 | 0.500 |
Why?
|
Myopathy, Central Core | 1 | 2014 | 4 | 0.500 |
Why?
|
Ultrasonography | 13 | 2019 | 5972 | 0.490 |
Why?
|
Oligonucleotides, Antisense | 4 | 2018 | 461 | 0.490 |
Why?
|
Intensive Care Units, Pediatric | 4 | 2024 | 1017 | 0.480 |
Why?
|
Action Potentials | 10 | 2018 | 1834 | 0.480 |
Why?
|
Male | 162 | 2024 | 360842 | 0.480 |
Why?
|
Muscle Strength | 6 | 2017 | 624 | 0.470 |
Why?
|
Critical Illness | 2 | 2024 | 2723 | 0.460 |
Why?
|
Hearing Loss, High-Frequency | 1 | 2013 | 11 | 0.450 |
Why?
|
Clinical Trials as Topic | 11 | 2020 | 8002 | 0.450 |
Why?
|
Collagen Type VI | 1 | 2013 | 25 | 0.450 |
Why?
|
Motor Skills | 8 | 2021 | 521 | 0.450 |
Why?
|
Wheelchairs | 1 | 2014 | 78 | 0.440 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2014 | 664 | 0.440 |
Why?
|
Spinal Curvatures | 1 | 2014 | 71 | 0.430 |
Why?
|
Deglutition | 3 | 2023 | 208 | 0.430 |
Why?
|
Olivopontocerebellar Atrophies | 1 | 2013 | 19 | 0.430 |
Why?
|
Quality of Life | 5 | 2024 | 13367 | 0.430 |
Why?
|
Muscle Hypotonia | 4 | 2022 | 161 | 0.430 |
Why?
|
Sclerosis | 1 | 2013 | 210 | 0.420 |
Why?
|
Mobility Limitation | 6 | 2021 | 408 | 0.420 |
Why?
|
Fatigue | 4 | 2024 | 1552 | 0.420 |
Why?
|
Motor Neuron Disease | 2 | 2010 | 97 | 0.410 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2012 | 34 | 0.410 |
Why?
|
Muscle Weakness | 5 | 2020 | 412 | 0.410 |
Why?
|
Plasma Exchange | 1 | 2012 | 159 | 0.390 |
Why?
|
Gene Duplication | 2 | 2012 | 314 | 0.370 |
Why?
|
Age Factors | 14 | 2021 | 18398 | 0.370 |
Why?
|
X Chromosome | 11 | 1998 | 816 | 0.370 |
Why?
|
Injections, Spinal | 6 | 2024 | 318 | 0.360 |
Why?
|
Genetic Association Studies | 4 | 2017 | 2735 | 0.360 |
Why?
|
Female | 134 | 2024 | 392686 | 0.350 |
Why?
|
Infant, Newborn | 24 | 2024 | 26198 | 0.350 |
Why?
|
Severity of Illness Index | 15 | 2024 | 15843 | 0.340 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 386 | 0.340 |
Why?
|
Polymorphism, Restriction Fragment Length | 12 | 1996 | 767 | 0.340 |
Why?
|
Codon, Nonsense | 2 | 2021 | 285 | 0.330 |
Why?
|
Peripheral Nervous System Diseases | 4 | 2016 | 710 | 0.330 |
Why?
|
Genetic Testing | 9 | 2023 | 3537 | 0.330 |
Why?
|
Chromosome Deletion | 10 | 1993 | 1386 | 0.330 |
Why?
|
Adaptor Protein Complex 4 | 2 | 2020 | 40 | 0.320 |
Why?
|
Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2008 | 23 | 0.310 |
Why?
|
Polyneuropathies | 4 | 2019 | 137 | 0.310 |
Why?
|
Metabolism, Inborn Errors | 3 | 2003 | 284 | 0.310 |
Why?
|
Myasthenia Gravis | 3 | 2019 | 214 | 0.300 |
Why?
|
Nerve Tissue Proteins | 5 | 2021 | 4415 | 0.280 |
Why?
|
Ventricular Premature Complexes | 1 | 2008 | 112 | 0.280 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 2006 | 27 | 0.280 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2009 | 477 | 0.270 |
Why?
|
Spastic Paraplegia, Hereditary | 2 | 2020 | 168 | 0.270 |
Why?
|
Neurologic Examination | 9 | 2016 | 916 | 0.270 |
Why?
|
Young Adult | 43 | 2024 | 59255 | 0.270 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 284 | 0.270 |
Why?
|
Spectrin | 2 | 2019 | 170 | 0.270 |
Why?
|
MELAS Syndrome | 1 | 2006 | 56 | 0.260 |
Why?
|
Frameshift Mutation | 1 | 2008 | 392 | 0.260 |
Why?
|
RNA-Binding Proteins | 2 | 2013 | 1897 | 0.260 |
Why?
|
Disease Management | 2 | 2018 | 2508 | 0.260 |
Why?
|
Leukodystrophy, Globoid Cell | 2 | 2001 | 38 | 0.260 |
Why?
|
Sciatic Neuropathy | 3 | 2011 | 76 | 0.250 |
Why?
|
Scoliosis | 4 | 2024 | 741 | 0.250 |
Why?
|
Sex Chromosome Aberrations | 3 | 1996 | 116 | 0.250 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1600 | 0.240 |
Why?
|
Longitudinal Studies | 18 | 2024 | 14607 | 0.240 |
Why?
|
DNA Mutational Analysis | 9 | 2013 | 4111 | 0.240 |
Why?
|
Dystonic Disorders | 1 | 2009 | 350 | 0.240 |
Why?
|
Walking | 6 | 2019 | 1198 | 0.240 |
Why?
|
Charcot-Marie-Tooth Disease | 2 | 2017 | 100 | 0.230 |
Why?
|
Prednisolone | 3 | 2021 | 326 | 0.230 |
Why?
|
Sequence Deletion | 4 | 2023 | 1494 | 0.220 |
Why?
|
Age of Onset | 8 | 2020 | 3306 | 0.220 |
Why?
|
Norepinephrine | 1 | 2006 | 897 | 0.220 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 2 | 2019 | 21 | 0.220 |
Why?
|
Electrodiagnosis | 5 | 2018 | 148 | 0.220 |
Why?
|
Cohort Studies | 23 | 2024 | 41493 | 0.220 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 3 | 2016 | 62 | 0.220 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 539 | 0.210 |
Why?
|
Alternative Splicing | 5 | 2023 | 1093 | 0.210 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3769 | 0.210 |
Why?
|
Therapies, Investigational | 1 | 2024 | 111 | 0.210 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 654 | 0.210 |
Why?
|
Chromosomes, Human, Pair 10 | 3 | 1994 | 277 | 0.210 |
Why?
|
Peroneal Nerve | 2 | 2017 | 76 | 0.210 |
Why?
|
Pediatrics | 5 | 2014 | 3589 | 0.200 |
Why?
|
Rhabdomyolysis | 2 | 2019 | 152 | 0.200 |
Why?
|
Recombinant Fusion Proteins | 2 | 2021 | 3733 | 0.200 |
Why?
|
Amino Acid Substitution | 3 | 2009 | 1739 | 0.200 |
Why?
|
Homozygote | 3 | 2023 | 1776 | 0.200 |
Why?
|
Nanopores | 1 | 2022 | 44 | 0.200 |
Why?
|
Muscles | 4 | 2015 | 1576 | 0.200 |
Why?
|
Peroneal Neuropathies | 2 | 2017 | 22 | 0.190 |
Why?
|
Femoral Neoplasms | 1 | 2002 | 84 | 0.190 |
Why?
|
Spinocerebellar Ataxias | 2 | 2013 | 105 | 0.190 |
Why?
|
Biological Products | 2 | 2021 | 914 | 0.190 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 2 | 2001 | 21 | 0.190 |
Why?
|
Adult | 56 | 2024 | 221203 | 0.190 |
Why?
|
Gene Deletion | 5 | 2015 | 2665 | 0.190 |
Why?
|
Reproducibility of Results | 15 | 2021 | 20099 | 0.190 |
Why?
|
Gigantism | 1 | 2001 | 15 | 0.190 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 41 | 0.190 |
Why?
|
Osteoma, Osteoid | 1 | 2002 | 90 | 0.190 |
Why?
|
Developmental Disabilities | 3 | 2013 | 1509 | 0.190 |
Why?
|
RNA Splice Sites | 2 | 2019 | 211 | 0.180 |
Why?
|
Genes, p53 | 2 | 1993 | 712 | 0.180 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2012 | 1469 | 0.180 |
Why?
|
Thymopoietins | 1 | 2000 | 10 | 0.180 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2016 | 710 | 0.180 |
Why?
|
Motor Activity | 6 | 2017 | 2715 | 0.180 |
Why?
|
Aptitude | 1 | 2020 | 43 | 0.180 |
Why?
|
Oxadiazoles | 1 | 2020 | 94 | 0.180 |
Why?
|
SMN Complex Proteins | 2 | 2012 | 41 | 0.170 |
Why?
|
Anti-Inflammatory Agents | 3 | 2019 | 1809 | 0.170 |
Why?
|
Clinical Competence | 2 | 2018 | 4793 | 0.170 |
Why?
|
Myofibrils | 2 | 2013 | 141 | 0.170 |
Why?
|
Paralyses, Familial Periodic | 1 | 2019 | 13 | 0.170 |
Why?
|
Multicenter Studies as Topic | 3 | 2022 | 1702 | 0.170 |
Why?
|
Hydroxyurea | 2 | 2013 | 284 | 0.170 |
Why?
|
Retrospective Studies | 24 | 2024 | 80646 | 0.160 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2019 | 40 | 0.160 |
Why?
|
Myotonia Congenita | 1 | 2019 | 16 | 0.160 |
Why?
|
Myelitis | 1 | 2019 | 49 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 6 | 2017 | 17904 | 0.160 |
Why?
|
Research Design | 4 | 2021 | 6180 | 0.160 |
Why?
|
Dopamine | 1 | 2006 | 1607 | 0.160 |
Why?
|
Consensus | 3 | 2024 | 3123 | 0.160 |
Why?
|
Glucocorticoids | 2 | 2022 | 2161 | 0.160 |
Why?
|
Aspartic Acid | 1 | 2001 | 576 | 0.160 |
Why?
|
Muscular Atrophy | 1 | 2002 | 334 | 0.160 |
Why?
|
Drugs, Investigational | 1 | 2021 | 212 | 0.160 |
Why?
|
Education, Medical, Graduate | 1 | 2011 | 2373 | 0.160 |
Why?
|
Double-Blind Method | 7 | 2021 | 12341 | 0.160 |
Why?
|
Steroids | 2 | 2018 | 929 | 0.150 |
Why?
|
Drug Design | 2 | 2013 | 1048 | 0.150 |
Why?
|
Cross-Sectional Studies | 8 | 2022 | 26127 | 0.150 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 128 | 0.150 |
Why?
|
Follow-Up Studies | 18 | 2024 | 39107 | 0.150 |
Why?
|
Valproic Acid | 2 | 2013 | 443 | 0.150 |
Why?
|
DNA | 13 | 2001 | 7213 | 0.150 |
Why?
|
Computers | 1 | 2021 | 593 | 0.150 |
Why?
|
Protein Isoforms | 2 | 2019 | 1699 | 0.150 |
Why?
|
Exons | 10 | 2019 | 2391 | 0.150 |
Why?
|
Neonatal Screening | 2 | 2020 | 597 | 0.150 |
Why?
|
Radial Neuropathy | 1 | 2018 | 26 | 0.150 |
Why?
|
Guillain-Barre Syndrome | 1 | 2019 | 127 | 0.150 |
Why?
|
Gene Dosage | 3 | 2020 | 1218 | 0.150 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 564 | 0.150 |
Why?
|
Genes | 9 | 1990 | 1823 | 0.150 |
Why?
|
Creatine Kinase | 2 | 2018 | 685 | 0.150 |
Why?
|
Pedigree | 14 | 2021 | 4542 | 0.140 |
Why?
|
Muscle Strength Dynamometer | 3 | 2014 | 41 | 0.140 |
Why?
|
Adaptation, Physiological | 2 | 2014 | 1301 | 0.140 |
Why?
|
Psychometrics | 4 | 2021 | 3065 | 0.140 |
Why?
|
Respiration Disorders | 1 | 2020 | 367 | 0.140 |
Why?
|
Neuropeptides | 1 | 2023 | 944 | 0.140 |
Why?
|
Channelopathies | 1 | 2017 | 30 | 0.140 |
Why?
|
Ulnar Neuropathies | 1 | 2017 | 32 | 0.140 |
Why?
|
Range of Motion, Articular | 3 | 2018 | 1588 | 0.140 |
Why?
|
Mice, Inbred mdx | 1 | 2016 | 88 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 13 | 2021 | 36429 | 0.140 |
Why?
|
Axons | 3 | 2019 | 1674 | 0.140 |
Why?
|
RNA, Messenger | 5 | 2019 | 12794 | 0.140 |
Why?
|
Arrhythmias, Cardiac | 1 | 2006 | 2244 | 0.130 |
Why?
|
Troponin I | 1 | 2021 | 651 | 0.130 |
Why?
|
Statistics as Topic | 5 | 2014 | 2358 | 0.130 |
Why?
|
Clonal Deletion | 1 | 1996 | 74 | 0.130 |
Why?
|
Serine | 1 | 2000 | 830 | 0.130 |
Why?
|
Thalidomide | 2 | 2016 | 885 | 0.130 |
Why?
|
Child Development | 5 | 2018 | 2306 | 0.130 |
Why?
|
Quadriceps Muscle | 1 | 2017 | 156 | 0.130 |
Why?
|
Biomedical Research | 1 | 2012 | 3429 | 0.130 |
Why?
|
Tibia | 1 | 2002 | 1070 | 0.130 |
Why?
|
Autistic Disorder | 1 | 2005 | 1220 | 0.130 |
Why?
|
Movement Disorders | 1 | 2020 | 459 | 0.130 |
Why?
|
Orthopedic Procedures | 3 | 2020 | 1265 | 0.130 |
Why?
|
Heterozygote | 6 | 2013 | 2787 | 0.130 |
Why?
|
Contracture | 1 | 2018 | 235 | 0.130 |
Why?
|
Body Height | 1 | 2022 | 1570 | 0.130 |
Why?
|
Corpus Callosum | 1 | 2020 | 751 | 0.130 |
Why?
|
Neurosciences | 1 | 2020 | 367 | 0.130 |
Why?
|
Elastic Modulus | 1 | 2016 | 211 | 0.130 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2017 | 263 | 0.120 |
Why?
|
Rett Syndrome | 2 | 1998 | 164 | 0.120 |
Why?
|
Stochastic Processes | 1 | 2016 | 355 | 0.120 |
Why?
|
Mutation, Missense | 3 | 2021 | 2571 | 0.120 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2022 | 846 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1001 | 0.120 |
Why?
|
Poliomyelitis | 2 | 2009 | 92 | 0.120 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 1994 | 418 | 0.120 |
Why?
|
Pyrroles | 1 | 2021 | 1125 | 0.120 |
Why?
|
Exercise Test | 2 | 2014 | 2127 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2206 | 0.120 |
Why?
|
Prospective Studies | 16 | 2024 | 54426 | 0.120 |
Why?
|
Observer Variation | 2 | 2018 | 2606 | 0.110 |
Why?
|
Lambert-Eaton Myasthenic Syndrome | 1 | 2013 | 8 | 0.110 |
Why?
|
Subcutaneous Fat | 2 | 2014 | 393 | 0.110 |
Why?
|
Cranial Nerve Diseases | 2 | 1986 | 113 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2017 | 4176 | 0.110 |
Why?
|
Astrocytoma | 3 | 1994 | 775 | 0.110 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1667 | 0.110 |
Why?
|
Knee Joint | 2 | 2018 | 1676 | 0.110 |
Why?
|
Desmin | 1 | 2013 | 99 | 0.110 |
Why?
|
Plasmapheresis | 1 | 2014 | 206 | 0.110 |
Why?
|
Microfilament Proteins | 2 | 2010 | 1134 | 0.110 |
Why?
|
Vital Capacity | 5 | 2017 | 971 | 0.110 |
Why?
|
Encephalomyelitis, Equine | 1 | 1992 | 13 | 0.110 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 1992 | 12 | 0.110 |
Why?
|
Foot Deformities | 1 | 2013 | 35 | 0.110 |
Why?
|
Membrane Proteins | 3 | 2012 | 7858 | 0.110 |
Why?
|
Polymorphism, Genetic | 4 | 2012 | 4243 | 0.110 |
Why?
|
Anisotropy | 1 | 2016 | 1283 | 0.110 |
Why?
|
Brain Neoplasms | 6 | 2004 | 9031 | 0.100 |
Why?
|
Myotonia | 1 | 2012 | 18 | 0.100 |
Why?
|
Lordosis | 1 | 2014 | 92 | 0.100 |
Why?
|
Genotype | 5 | 2017 | 12990 | 0.100 |
Why?
|
Rare Diseases | 1 | 2018 | 622 | 0.100 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2010 | 173 | 0.100 |
Why?
|
Medulloblastoma | 2 | 2000 | 678 | 0.100 |
Why?
|
Dynamin II | 1 | 2012 | 35 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 1996 | 1768 | 0.100 |
Why?
|
Muscle Spasticity | 1 | 2013 | 156 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 532 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 2 | 1993 | 1062 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 4740 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 9002 | 0.100 |
Why?
|
Benchmarking | 1 | 2018 | 1045 | 0.100 |
Why?
|
Glycerol Kinase | 2 | 1988 | 17 | 0.100 |
Why?
|
Hip Joint | 1 | 2018 | 1014 | 0.100 |
Why?
|
Kyphosis | 1 | 2014 | 237 | 0.090 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 452 | 0.090 |
Why?
|
Brain | 7 | 2017 | 27120 | 0.090 |
Why?
|
Base Sequence | 10 | 2016 | 12441 | 0.090 |
Why?
|
Oligodendroglioma | 1 | 1993 | 279 | 0.090 |
Why?
|
Fatal Outcome | 3 | 2017 | 1835 | 0.090 |
Why?
|
Checklist | 1 | 2018 | 827 | 0.090 |
Why?
|
Treatment Outcome | 13 | 2024 | 64684 | 0.090 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2012 | 126 | 0.090 |
Why?
|
Genes, Dominant | 2 | 2012 | 852 | 0.090 |
Why?
|
Glioblastoma | 4 | 1994 | 3482 | 0.090 |
Why?
|
Diagnosis, Differential | 8 | 2016 | 12975 | 0.090 |
Why?
|
Genetic Markers | 4 | 2009 | 2601 | 0.090 |
Why?
|
Body Composition | 2 | 2018 | 2426 | 0.090 |
Why?
|
Phosphotransferases | 2 | 1988 | 303 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10212 | 0.090 |
Why?
|
Prenatal Diagnosis | 2 | 1988 | 1265 | 0.090 |
Why?
|
United States | 7 | 2023 | 72335 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1202 | 0.090 |
Why?
|
Middle Aged | 31 | 2024 | 220920 | 0.090 |
Why?
|
Transaminases | 1 | 2010 | 198 | 0.090 |
Why?
|
Teaching | 1 | 2018 | 1170 | 0.090 |
Why?
|
Brachial Plexus Neuritis | 1 | 2009 | 20 | 0.090 |
Why?
|
Thigh | 1 | 2011 | 241 | 0.090 |
Why?
|
Ultrasonography, Doppler | 1 | 2012 | 462 | 0.090 |
Why?
|
Sural Nerve | 2 | 2006 | 105 | 0.080 |
Why?
|
Hartnup Disease | 1 | 1989 | 4 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2002 | 2529 | 0.080 |
Why?
|
Nutritional Status | 1 | 2018 | 1615 | 0.080 |
Why?
|
Animals | 18 | 2023 | 168467 | 0.080 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2009 | 17 | 0.080 |
Why?
|
Hand | 1 | 2015 | 903 | 0.080 |
Why?
|
Point Mutation | 2 | 2001 | 1595 | 0.080 |
Why?
|
Molecular Sequence Data | 11 | 2012 | 17635 | 0.080 |
Why?
|
Prognosis | 7 | 2018 | 29629 | 0.080 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 957 | 0.080 |
Why?
|
Choline O-Acetyltransferase | 1 | 2009 | 156 | 0.080 |
Why?
|
Pyridines | 1 | 2021 | 2875 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1007 | 0.080 |
Why?
|
Brain Chemistry | 3 | 2008 | 960 | 0.080 |
Why?
|
Myotonic Dystrophy | 2 | 2018 | 78 | 0.080 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1993 | 592 | 0.080 |
Why?
|
Immunomodulation | 1 | 2012 | 549 | 0.080 |
Why?
|
Respiratory Mechanics | 1 | 2012 | 699 | 0.080 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2008 | 578 | 0.080 |
Why?
|
Biopsy | 3 | 2017 | 6766 | 0.080 |
Why?
|
Polymerase Chain Reaction | 4 | 2009 | 6075 | 0.080 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1988 | 228 | 0.080 |
Why?
|
Thymectomy | 1 | 2009 | 195 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2013 | 727 | 0.080 |
Why?
|
Regression Analysis | 3 | 2019 | 6344 | 0.080 |
Why?
|
Registries | 2 | 2021 | 8224 | 0.080 |
Why?
|
Meningococcal Infections | 1 | 2008 | 77 | 0.080 |
Why?
|
Mental Retardation, X-Linked | 1 | 2008 | 41 | 0.080 |
Why?
|
Friedreich Ataxia | 1 | 2008 | 77 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2021 | 4937 | 0.070 |
Why?
|
Gene Rearrangement | 2 | 1992 | 1125 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2011 | 3359 | 0.070 |
Why?
|
Apnea | 1 | 2009 | 195 | 0.070 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2007 | 110 | 0.070 |
Why?
|
Blood Proteins | 1 | 2013 | 1173 | 0.070 |
Why?
|
Gait Disorders, Neurologic | 2 | 2013 | 240 | 0.070 |
Why?
|
Phenylbutyrates | 1 | 2007 | 72 | 0.070 |
Why?
|
Meningioma | 1 | 1996 | 1218 | 0.070 |
Why?
|
Neurodegenerative Diseases | 1 | 2016 | 1088 | 0.070 |
Why?
|
Myelin Proteolipid Protein | 1 | 2007 | 107 | 0.070 |
Why?
|
Cofilin 2 | 1 | 2006 | 12 | 0.070 |
Why?
|
Propanolamines | 1 | 2007 | 163 | 0.070 |
Why?
|
Meningeal Neoplasms | 1 | 1996 | 1248 | 0.070 |
Why?
|
Patient Participation | 1 | 2016 | 1445 | 0.070 |
Why?
|
Huntington Disease | 2 | 2004 | 1144 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3517 | 0.070 |
Why?
|
Disabled Persons | 1 | 2016 | 1225 | 0.070 |
Why?
|
Alleles | 6 | 2017 | 6864 | 0.070 |
Why?
|
Language Development Disorders | 1 | 2008 | 193 | 0.070 |
Why?
|
Ventricular Function | 1 | 2008 | 406 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2498 | 0.070 |
Why?
|
Italy | 2 | 2020 | 842 | 0.070 |
Why?
|
Vasculitis | 2 | 2008 | 521 | 0.070 |
Why?
|
Family Health | 2 | 2013 | 1257 | 0.070 |
Why?
|
Frontal Lobe | 1 | 1993 | 1420 | 0.070 |
Why?
|
Statistics, Nonparametric | 4 | 2014 | 2850 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2013 | 829 | 0.070 |
Why?
|
Proteins | 2 | 2013 | 6032 | 0.070 |
Why?
|
Carbazoles | 1 | 2007 | 220 | 0.070 |
Why?
|
Membrane Glycoproteins | 2 | 2010 | 3701 | 0.070 |
Why?
|
Creatine | 1 | 2008 | 427 | 0.060 |
Why?
|
DNA Probes | 5 | 1996 | 541 | 0.060 |
Why?
|
Time Factors | 4 | 2019 | 39970 | 0.060 |
Why?
|
Spinal Fusion | 2 | 2024 | 1286 | 0.060 |
Why?
|
Electron Transport Complex IV | 3 | 1991 | 190 | 0.060 |
Why?
|
Electric Stimulation | 1 | 2010 | 1736 | 0.060 |
Why?
|
Blotting, Southern | 4 | 2000 | 777 | 0.060 |
Why?
|
Dystonia | 1 | 1989 | 370 | 0.060 |
Why?
|
Flatfoot | 1 | 2006 | 60 | 0.060 |
Why?
|
Chromosomes | 1 | 1988 | 578 | 0.060 |
Why?
|
Crohn Disease | 2 | 2016 | 2279 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7391 | 0.060 |
Why?
|
Algorithms | 7 | 2019 | 14032 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 502 | 0.060 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 1986 | 64 | 0.060 |
Why?
|
Chromosome Mapping | 10 | 2010 | 4615 | 0.060 |
Why?
|
Glycine | 1 | 2008 | 663 | 0.060 |
Why?
|
Acute Disease | 2 | 2009 | 7237 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6770 | 0.060 |
Why?
|
Databases, Genetic | 1 | 2011 | 1742 | 0.060 |
Why?
|
Mononeuropathies | 1 | 2003 | 13 | 0.060 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 2003 | 51 | 0.060 |
Why?
|
Syndrome | 2 | 2001 | 3267 | 0.060 |
Why?
|
Motor Skills Disorders | 1 | 2004 | 89 | 0.060 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 2004 | 44 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1567 | 0.060 |
Why?
|
Respiratory System | 1 | 2007 | 563 | 0.050 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2003 | 71 | 0.050 |
Why?
|
Evoked Potentials, Visual | 1 | 1986 | 417 | 0.050 |
Why?
|
Databases, Factual | 1 | 2019 | 7967 | 0.050 |
Why?
|
Dystroglycans | 1 | 2023 | 62 | 0.050 |
Why?
|
Child Behavior Disorders | 1 | 2008 | 804 | 0.050 |
Why?
|
Neuritis | 1 | 1983 | 36 | 0.050 |
Why?
|
Immune Complex Diseases | 1 | 1983 | 50 | 0.050 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2023 | 59 | 0.050 |
Why?
|
Absorptiometry, Photon | 3 | 2018 | 1738 | 0.050 |
Why?
|
Fever of Unknown Origin | 1 | 1983 | 94 | 0.050 |
Why?
|
Enterovirus Infections | 1 | 1983 | 74 | 0.050 |
Why?
|
Evoked Potentials, Auditory | 1 | 1986 | 530 | 0.050 |
Why?
|
Cytoskeletal Proteins | 2 | 2013 | 1342 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 6965 | 0.050 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2008 | 1310 | 0.050 |
Why?
|
Arm | 2 | 2017 | 589 | 0.050 |
Why?
|
Orthotic Devices | 1 | 2003 | 129 | 0.050 |
Why?
|
Pyridostigmine Bromide | 2 | 2014 | 32 | 0.050 |
Why?
|
Mice | 5 | 2023 | 81533 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 14666 | 0.050 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2003 | 247 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2767 | 0.050 |
Why?
|
Thromboembolism | 1 | 2008 | 995 | 0.050 |
Why?
|
Aged | 9 | 2023 | 169310 | 0.050 |
Why?
|
Anthropometry | 3 | 2011 | 1349 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1241 | 0.050 |
Why?
|
Aging | 2 | 2018 | 8711 | 0.050 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 556 | 0.050 |
Why?
|
Fetal Diseases | 1 | 1987 | 913 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 5 | 1990 | 1302 | 0.050 |
Why?
|
Erythema | 1 | 1983 | 262 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1964 | 0.050 |
Why?
|
Genetic Variation | 2 | 2013 | 6567 | 0.050 |
Why?
|
Myotonic Disorders | 1 | 2000 | 7 | 0.050 |
Why?
|
Neurotrophin 3 | 1 | 2001 | 61 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3600 | 0.050 |
Why?
|
International Cooperation | 2 | 2018 | 1422 | 0.050 |
Why?
|
Epiphyses | 1 | 2002 | 190 | 0.050 |
Why?
|
Protein Conformation | 3 | 2021 | 3968 | 0.050 |
Why?
|
Peripheral Nerves | 1 | 2004 | 479 | 0.050 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2002 | 204 | 0.050 |
Why?
|
Brain Death | 1 | 2004 | 357 | 0.050 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 329 | 0.050 |
Why?
|
Asia | 1 | 2022 | 619 | 0.050 |
Why?
|
Pseudogenes | 2 | 1991 | 104 | 0.050 |
Why?
|
Models, Molecular | 3 | 2021 | 5439 | 0.040 |
Why?
|
Restriction Mapping | 6 | 1991 | 851 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2006 | 2079 | 0.040 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2000 | 14 | 0.040 |
Why?
|
Adiposity | 1 | 2010 | 1879 | 0.040 |
Why?
|
Glycogen Storage Disease | 1 | 2000 | 41 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2017 | 2630 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2010 | 2639 | 0.040 |
Why?
|
Amino Acid Sequence | 9 | 2012 | 13446 | 0.040 |
Why?
|
Mitochondrial Myopathies | 1 | 2000 | 50 | 0.040 |
Why?
|
Metabolic Diseases | 2 | 2003 | 683 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2009 | 1589 | 0.040 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2000 | 127 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 470 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10766 | 0.040 |
Why?
|
DNA, Neoplasm | 3 | 1994 | 1745 | 0.040 |
Why?
|
Choline | 1 | 2001 | 515 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3612 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2000 | 123 | 0.040 |
Why?
|
Amyloidosis | 1 | 1986 | 817 | 0.040 |
Why?
|
Cognition | 2 | 2014 | 6992 | 0.040 |
Why?
|
Deltoid Muscle | 1 | 2018 | 18 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 2 | 1991 | 313 | 0.040 |
Why?
|
Receptors, Bombesin | 1 | 1998 | 27 | 0.040 |
Why?
|
Mitochondrial Diseases | 1 | 2002 | 343 | 0.040 |
Why?
|
Osteochondrodysplasias | 1 | 2000 | 182 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2013 | 2180 | 0.040 |
Why?
|
Leg | 2 | 2017 | 1088 | 0.040 |
Why?
|
Contracts | 1 | 2018 | 60 | 0.040 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 1990 | 343 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22172 | 0.040 |
Why?
|
Nuclear Proteins | 3 | 2003 | 5799 | 0.040 |
Why?
|
Abnormalities, Multiple | 2 | 2001 | 1423 | 0.040 |
Why?
|
Spinal Cord | 1 | 2006 | 1819 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 1541 | 0.040 |
Why?
|
Linear Models | 2 | 2021 | 5872 | 0.040 |
Why?
|
Glioma | 1 | 1993 | 3455 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2012 | 2578 | 0.040 |
Why?
|
Family | 3 | 2021 | 3194 | 0.040 |
Why?
|
Paralysis, Hyperkalemic Periodic | 1 | 2017 | 5 | 0.040 |
Why?
|
Stroke Volume | 2 | 2008 | 5496 | 0.040 |
Why?
|
Massachusetts | 2 | 2005 | 8830 | 0.040 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 1988 | 166 | 0.040 |
Why?
|
Andersen Syndrome | 1 | 2017 | 5 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 2017 | 2421 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15633 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2018 | 369 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 3713 | 0.030 |
Why?
|
Distal Myopathies | 1 | 2016 | 18 | 0.030 |
Why?
|
Facies | 1 | 2017 | 222 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2001 | 602 | 0.030 |
Why?
|
Ulnar Nerve | 1 | 2017 | 102 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2001 | 610 | 0.030 |
Why?
|
Budgets | 1 | 2018 | 230 | 0.030 |
Why?
|
Sample Size | 1 | 2019 | 841 | 0.030 |
Why?
|
Heart Function Tests | 1 | 2017 | 318 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 1992 | 20571 | 0.030 |
Why?
|
Movement | 2 | 2015 | 1479 | 0.030 |
Why?
|
RNA Splicing | 1 | 2021 | 918 | 0.030 |
Why?
|
Time | 1 | 2018 | 546 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6312 | 0.030 |
Why?
|
Growth Disorders | 1 | 2001 | 655 | 0.030 |
Why?
|
Electroencephalography | 3 | 2008 | 6237 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3422 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1003 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 1988 | 3847 | 0.030 |
Why?
|
Bacterial Infections | 1 | 1983 | 1391 | 0.030 |
Why?
|
Cerebellar Neoplasms | 1 | 2000 | 586 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2018 | 728 | 0.030 |
Why?
|
Meninges | 1 | 1996 | 198 | 0.030 |
Why?
|
Caregivers | 2 | 2017 | 2238 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9469 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18253 | 0.030 |
Why?
|
Pressure | 1 | 2017 | 1154 | 0.030 |
Why?
|
Locomotion | 1 | 2016 | 388 | 0.030 |
Why?
|
Delphi Technique | 1 | 2018 | 846 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2018 | 697 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2024 | 9177 | 0.030 |
Why?
|
Language Tests | 1 | 2014 | 190 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
Automation | 2 | 2009 | 586 | 0.030 |
Why?
|
Gene Expression | 2 | 2018 | 7581 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6484 | 0.030 |
Why?
|
Pilot Projects | 2 | 2017 | 8633 | 0.030 |
Why?
|
Hand Strength | 1 | 2016 | 456 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 1010 | 0.030 |
Why?
|
Neoplasms | 2 | 2011 | 22173 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6485 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2017 | 653 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4021 | 0.030 |
Why?
|
Dosage Compensation, Genetic | 1 | 1994 | 207 | 0.030 |
Why?
|
Deoxyribonuclease HindIII | 2 | 1989 | 14 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10090 | 0.030 |
Why?
|
Hypesthesia | 1 | 2013 | 107 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 945 | 0.030 |
Why?
|
Models, Neurological | 1 | 2020 | 1769 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1230 | 0.020 |
Why?
|
Genes, Recessive | 2 | 2012 | 623 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5672 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2014 | 794 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 1992 | 267 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2013 | 239 | 0.020 |
Why?
|
Aftercare | 1 | 2018 | 914 | 0.020 |
Why?
|
Collagen | 1 | 2000 | 2638 | 0.020 |
Why?
|
Critical Care | 1 | 2004 | 2697 | 0.020 |
Why?
|
Zebrafish | 2 | 2013 | 3007 | 0.020 |
Why?
|
Seizures | 1 | 2004 | 2957 | 0.020 |
Why?
|
DNA Restriction Enzymes | 2 | 1988 | 550 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2011 | 15266 | 0.020 |
Why?
|
Focus Groups | 1 | 2017 | 1413 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 2 | 1988 | 576 | 0.020 |
Why?
|
Echocardiography | 3 | 2008 | 4989 | 0.020 |
Why?
|
Extremities | 1 | 2016 | 867 | 0.020 |
Why?
|
Comorbidity | 1 | 2005 | 10508 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 976 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23447 | 0.020 |
Why?
|
Reaction Time | 1 | 2017 | 2089 | 0.020 |
Why?
|
Patients | 1 | 2017 | 907 | 0.020 |
Why?
|
Philadelphia | 1 | 2011 | 266 | 0.020 |
Why?
|
Energy Intake | 1 | 2018 | 2134 | 0.020 |
Why?
|
Phosphorylase Kinase | 1 | 1989 | 9 | 0.020 |
Why?
|
Knee | 1 | 2011 | 279 | 0.020 |
Why?
|
Hybrid Cells | 4 | 1991 | 422 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1712 | 0.020 |
Why?
|
Trihexyphenidyl | 1 | 1989 | 4 | 0.020 |
Why?
|
Population | 1 | 2009 | 141 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1990 | 287 | 0.020 |
Why?
|
Cloning, Molecular | 3 | 1991 | 4174 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3205 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4853 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2020 | 0.020 |
Why?
|
Vidarabine | 1 | 2010 | 336 | 0.020 |
Why?
|
Antibodies, Neoplasm | 1 | 2010 | 281 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2011 | 438 | 0.020 |
Why?
|
Prevalence | 1 | 2005 | 15732 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2696 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2010 | 321 | 0.020 |
Why?
|
Endoribonucleases | 1 | 1990 | 228 | 0.020 |
Why?
|
Umbilical Arteries | 1 | 2008 | 79 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1989 | 410 | 0.020 |
Why?
|
Niacin | 1 | 1989 | 118 | 0.020 |
Why?
|
Pentosyltransferases | 1 | 2007 | 62 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1990 | 535 | 0.020 |
Why?
|
Blepharoptosis | 1 | 2009 | 144 | 0.020 |
Why?
|
Haplotypes | 2 | 2000 | 2713 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 1989 | 190 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1989 | 322 | 0.020 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2007 | 69 | 0.020 |
Why?
|
Midazolam | 1 | 2009 | 266 | 0.020 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2008 | 97 | 0.020 |
Why?
|
Oligoclonal Bands | 1 | 2007 | 17 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2009 | 242 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12059 | 0.020 |
Why?
|
Leukocytes | 2 | 1994 | 2026 | 0.020 |
Why?
|
Myosins | 1 | 1989 | 405 | 0.020 |
Why?
|
Crossing Over, Genetic | 1 | 1987 | 92 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6815 | 0.020 |
Why?
|
Tryptophan | 1 | 1989 | 482 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2018 | 2882 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9646 | 0.020 |
Why?
|
Meiosis | 1 | 1988 | 328 | 0.020 |
Why?
|
Molecular Biology | 1 | 1990 | 576 | 0.020 |
Why?
|
Rats | 2 | 2014 | 23741 | 0.020 |
Why?
|
Cell Separation | 1 | 1992 | 1720 | 0.020 |
Why?
|
Goats | 1 | 1986 | 165 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6426 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4244 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2009 | 1163 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9541 | 0.020 |
Why?
|
Facial Nerve Diseases | 1 | 1986 | 49 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2192 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4077 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2007 | 385 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1682 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2011 | 970 | 0.020 |
Why?
|
Arteriovenous Malformations | 1 | 2008 | 396 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2819 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3579 | 0.020 |
Why?
|
Interferon-beta | 1 | 2007 | 345 | 0.020 |
Why?
|
Cerebellar Diseases | 1 | 2007 | 220 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1990 | 2341 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2008 | 542 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3461 | 0.010 |
Why?
|
Language | 1 | 2014 | 1540 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1987 | 552 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2220 | 0.010 |
Why?
|
Mosaicism | 1 | 1987 | 475 | 0.010 |
Why?
|
Swine | 1 | 2014 | 5915 | 0.010 |
Why?
|
Biological Evolution | 1 | 1990 | 1071 | 0.010 |
Why?
|
North America | 1 | 2007 | 1276 | 0.010 |
Why?
|
Scapula | 1 | 2005 | 173 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2281 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2257 | 0.010 |
Why?
|
Neurotoxins | 1 | 2004 | 240 | 0.010 |
Why?
|
Thoracic Wall | 1 | 2005 | 202 | 0.010 |
Why?
|
Germ Cells | 1 | 1987 | 634 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3530 | 0.010 |
Why?
|
Mitosis | 1 | 1988 | 1188 | 0.010 |
Why?
|
Ulcer | 1 | 2004 | 204 | 0.010 |
Why?
|
Aortic Valve Stenosis | 2 | 1988 | 2001 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18965 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14416 | 0.010 |
Why?
|
Electrophysiology | 1 | 1986 | 1262 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1986 | 1705 | 0.010 |
Why?
|
Ticks | 1 | 1983 | 70 | 0.010 |
Why?
|
Catheterization | 1 | 2008 | 1428 | 0.010 |
Why?
|
Macromolecular Substances | 3 | 1990 | 1434 | 0.010 |
Why?
|
Heart Atria | 1 | 1989 | 1345 | 0.010 |
Why?
|
Respiration | 1 | 2009 | 1657 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2004 | 374 | 0.010 |
Why?
|
Cricetinae | 3 | 1991 | 2423 | 0.010 |
Why?
|
Sarcoglycans | 1 | 2002 | 57 | 0.010 |
Why?
|
Meningoencephalitis | 1 | 1983 | 83 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2007 | 1515 | 0.010 |
Why?
|
Bites and Stings | 1 | 1983 | 93 | 0.010 |
Why?
|
Lamins | 1 | 2001 | 37 | 0.010 |
Why?
|
Lysine | 1 | 2006 | 993 | 0.010 |
Why?
|
Ependymoma | 1 | 2004 | 320 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 2004 | 351 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4807 | 0.010 |
Why?
|
Dark Adaptation | 1 | 2002 | 222 | 0.010 |
Why?
|
Mitochondria, Muscle | 1 | 2002 | 172 | 0.010 |
Why?
|
Bacteremia | 1 | 2008 | 980 | 0.010 |
Why?
|
Risk Factors | 2 | 2009 | 74213 | 0.010 |
Why?
|
Hypnotics and Sedatives | 1 | 2009 | 1179 | 0.010 |
Why?
|
Remission Induction | 1 | 2007 | 2397 | 0.010 |
Why?
|
Evaluation Studies as Topic | 3 | 1988 | 1624 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2010 | 11904 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1186 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2006 | 1176 | 0.010 |
Why?
|
Lamin Type A | 1 | 2001 | 189 | 0.010 |
Why?
|
Withholding Treatment | 1 | 2004 | 617 | 0.010 |
Why?
|
Electroretinography | 1 | 2002 | 525 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12954 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2002 | 413 | 0.010 |
Why?
|
Ankle | 1 | 2003 | 351 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9326 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2011 | 58986 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10721 | 0.010 |
Why?
|
Central Nervous System | 1 | 2007 | 1336 | 0.010 |
Why?
|
Reoperation | 1 | 2010 | 4303 | 0.010 |
Why?
|
Proteomics | 1 | 2013 | 3848 | 0.010 |
Why?
|
Genetic Counseling | 1 | 2003 | 627 | 0.010 |
Why?
|
Foot | 1 | 2003 | 575 | 0.010 |
Why?
|
Actins | 1 | 2006 | 2050 | 0.010 |
Why?
|
Vision, Ocular | 1 | 2002 | 455 | 0.010 |
Why?
|
Overweight | 1 | 2010 | 2417 | 0.010 |
Why?
|
Heart Ventricles | 2 | 2007 | 3807 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2010 | 3575 | 0.010 |
Why?
|
Electrocardiography | 2 | 2008 | 6377 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1418 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7396 | 0.010 |
Why?
|
Cornea | 1 | 1986 | 1333 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13255 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 2001 | 902 | 0.010 |
Why?
|
Cricetulus | 2 | 1990 | 814 | 0.010 |
Why?
|
Pain | 1 | 2013 | 5073 | 0.010 |
Why?
|
Seasons | 1 | 1983 | 1520 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6241 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2002 | 865 | 0.010 |
Why?
|
Liver | 2 | 1990 | 7529 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1986 | 1400 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1989 | 5112 | 0.010 |
Why?
|
Cartilage | 1 | 2000 | 806 | 0.010 |
Why?
|
Myocardium | 1 | 1989 | 4725 | 0.010 |
Why?
|
Pregnancy | 2 | 1988 | 29876 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8321 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2693 | 0.010 |
Why?
|
Species Specificity | 2 | 1990 | 2414 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2007 | 3879 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1993 | 9280 | 0.010 |
Why?
|
Escherichia coli | 1 | 2006 | 4217 | 0.010 |
Why?
|
Erythrocytes | 1 | 2003 | 2413 | 0.010 |
Why?
|
Phosphoglycerate Kinase | 1 | 1994 | 66 | 0.010 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1994 | 69 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2003 | 2319 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4575 | 0.010 |
Why?
|
Nitroblue Tetrazolium | 1 | 1990 | 17 | 0.010 |
Why?
|
Base Composition | 1 | 1991 | 290 | 0.010 |
Why?
|
Clone Cells | 1 | 1994 | 1659 | 0.010 |
Why?
|
Aneuploidy | 1 | 1994 | 552 | 0.010 |
Why?
|
Reading Frames | 1 | 1989 | 17 | 0.010 |
Why?
|
Genomic Library | 1 | 1990 | 189 | 0.010 |
Why?
|
Pan troglodytes | 1 | 1990 | 223 | 0.010 |
Why?
|
Myosin Subfragments | 1 | 1989 | 20 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1990 | 1058 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1989 | 11461 | 0.000 |
Why?
|
Aortic Valve | 2 | 1988 | 1955 | 0.000 |
Why?
|
Introns | 1 | 1991 | 981 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2002 | 11076 | 0.000 |
Why?
|
Primates | 1 | 1990 | 523 | 0.000 |
Why?
|
Inflammation | 1 | 2007 | 10773 | 0.000 |
Why?
|
Rheology | 1 | 1988 | 347 | 0.000 |
Why?
|
Chromosome Banding | 1 | 1987 | 260 | 0.000 |
Why?
|
Mathematics | 1 | 1988 | 707 | 0.000 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1986 | 30 | 0.000 |
Why?
|
Phonocardiography | 1 | 1986 | 30 | 0.000 |
Why?
|
Heart Auscultation | 1 | 1986 | 33 | 0.000 |
Why?
|
Systole | 1 | 1988 | 936 | 0.000 |
Why?
|
Diastole | 1 | 1988 | 782 | 0.000 |
Why?
|
Echocardiography, Doppler | 1 | 1989 | 897 | 0.000 |
Why?
|
Transcription, Genetic | 2 | 1989 | 7593 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1983 | 7407 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1988 | 1371 | 0.000 |
Why?
|
Organ Specificity | 1 | 1989 | 1968 | 0.000 |
Why?
|
Cattle | 1 | 1990 | 3849 | 0.000 |
Why?
|
Cell Line | 2 | 1989 | 15601 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 1741 | 0.000 |
Why?
|
Rabbits | 1 | 1988 | 4772 | 0.000 |
Why?
|
Neoplasm Proteins | 1 | 1994 | 3617 | 0.000 |
Why?
|
Angiography | 1 | 1986 | 1595 | 0.000 |
Why?
|
Lymphocytes | 1 | 1987 | 2612 | 0.000 |
Why?
|
Endocarditis | 1 | 1982 | 348 | 0.000 |
Why?
|
Hemodynamics | 1 | 1988 | 4160 | 0.000 |
Why?
|
Aortic Aneurysm | 1 | 1982 | 648 | 0.000 |
Why?
|
Aorta | 1 | 1982 | 2041 | 0.000 |
Why?
|